We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Recommends Janssen’s Olysio for Hepatitis C for Genotype 1 and 4
NICE Recommends Janssen’s Olysio for Hepatitis C for Genotype 1 and 4
The UK’s health cost-benefit watchdog is recommending coverage of Janssen’s drug Olysio as a treatment option for people with both genotype 1 and genotype 4 hepatitis C.